明基医院集团股份有限公司（02581）于2026年8月6日发布截至2026年7月31日的证券变动月报显示，公司法定股本及已发行股份本期无新增或减少，整体股本规模保持稳定。
据公告披露，公司注册股本维持在500,000,000股，面值为每股1美元，总额约5亿美元。于期末，公司已发行股份数量为311,945,001股，与上月持平，期间并无新增发行、回购或注销股票活动，亦无库藏股变动。
在股权激励方面，首次公开发售前购股权计划于本月有84,000股购股权因期限到期而失效，期末剩余购股权数量为2,682,500股。根据公告，上市规则要求的公众持股量得以维持，公司仍符合相关上市规定。
本次公告由董事萧泽荣签署。公司方面表示将继续遵守香港联合交易所有限公司主板上市规则以及相关法律法规要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.